Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > BIOL Biolase > Company Executives
BIOL Biolase
0.582
+0.019+3.37%
Pre Mkt Price
0.580
-0.002-0.36%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. John R. BeaverDirector, President, Chief Executive Officer and Principal Accounting Officer880.80K----60male03/30/2022
Ms. Jennifer BrightChief Financial Officer------51female07/07/2022
Mr. Steven SandorChief Operating Officer------42male07/07/2022
Dr. Jonathan T. Lord,M.D.Chairman of the Board690.08K----66male03/30/2022
Mr. Jess RoperIndependent Director333.02K----56male03/30/2022
Ms. Martha Somerman, D.D.S.Independent Director104.17K----75female03/30/2022
Ms. Carol Gomez Summerhays, D.D.S.Independent Director104.17K----68female03/30/2022
Ms. Kathleen T. O'Loughlin, D.D.S.Independent Director------71female03/30/2022
Dr. Kenneth P. Yale, D.D.S.,J.D.Independent Director------65male05/02/2022
Company Overview More
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
CEO: Mr. John R. Beaver
Market: NASDAQ
Listing Date: 11/12/1992
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist